8-bromo cyclic adenosine monophosphate has been researched along with Cytomegalovirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, H; Hamajima, K; Kudoh, I; Lu, Y; Okuda, K; Suzuki, M; Takahashi, T; Toda, S; Watabe, S; Xin, KQ | 1 |
1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Cytomegalovirus
Article | Year |
---|---|
8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Administration, Intranasal; Animals; Combined Modality Therapy; Cytomegalovirus; Dose-Response Relationship, Drug; Genetic Therapy; Genetic Vectors; HIV Envelope Protein gp160; Hypersensitivity, Delayed; Immunoglobulin G; Injections, Intramuscular; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Promoter Regions, Genetic; T-Lymphocytes, Cytotoxic; Vaccines, DNA | 2000 |